Treatment abandonment and refusal among children with central nervous system tumors in Jordan

被引:3
|
作者
Amayiri, Nisreen [1 ]
Bouffet, Eric [2 ]
机构
[1] King Hussein Canc Ctr, Div Pediat Hematol Oncol, 202 Queen Rania Al Abdullah St,POB 1269, Amman 11941, Jordan
[2] Hosp Sick Children, Div Hematol Oncol, Toronto, ON, Canada
关键词
abandonment; LMIC; pediatric CNS tumors; ACUTE LYMPHOBLASTIC-LEUKEMIA; CANCER;
D O I
10.1002/pbc.29054
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Treatment abandonment and refusal are reported to contribute significantly to poor survival of children with cancer in low- and middle-income countries. We aimed to assess this phenomenon among children diagnosed with central nervous system (CNS) tumors in Jordan. Methods We retrospectively reviewed the medical charts of children <18 years diagnosed with CNS tumors (2010-2020). Patients who abandoned or refused part of treatment were reviewed for their clinical characteristics, social circumstances, and possible reasons. We excluded patients referred for second opinion, radiotherapy only, or who traveled abroad for treatment. Results Four hundred seventy-three Jordanian children were identified; 12 families (2.5%) abandoned treatment, and 15 refused part of therapy (3%). Most patients were females (67%) and most had good or moderate performance status (89%). Most families (93%) lived within 2 hours from King Hussein Cancer Center. Most parents were university graduates (71%) and all fathers were employed, while 71% of mothers were housewives. The most common reasons to abandon or refuse therapy were treatment intensity in view of poor tumor outcome or bad quality of life, conflicting recommendations from other health care providers, "personal beliefs" against chemotherapy, and preference to use alternative medicine. Conclusions Treatment abandonment and refusal in Jordanian children with CNS tumors is low. Universal cancer insurance, high level of education in the country, centralized cancer care in one institution, and the twinning program likely contributed to our low incidence. Improving knowledge on CNS tumors and better community rehabilitation and supportive services may help further decrease the abandonment and treatment refusal rate.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Clinical outcomes following proton therapy for children with central nervous system tumors referred overseas
    Indelicato, Daniel J.
    Bradley, Julie A.
    Sandler, Eric S.
    Aldana, Philipp R.
    Sapp, Amy
    Gains, Jennifer E.
    Crellin, Adrian
    Rotondo, Ronny L.
    PEDIATRIC BLOOD & CANCER, 2017, 64 (12)
  • [32] A report about treatment refusal and abandonment in children with acute lymphoblastic leukemia in China, 1997-2007
    Wang, Yan-rong
    Jin, Run-ming
    Xu, Jia-wei
    Zhang, Zhi-quan
    LEUKEMIA RESEARCH, 2011, 35 (12) : 1628 - 1631
  • [33] Pesticide exposure and risk of Central Nervous System tumors in children: a systematic review with meta-analysis
    Mota, Anne Livia Cavalcante
    Barbosa, Isadora Marques
    Rodrigues, Andrea Bezerra
    Chaves, Edna Maria Camelo
    de Almeida, Paulo Cesar
    CIENCIA & SAUDE COLETIVA, 2023, 28 (09): : 2583 - 2594
  • [34] The Role of Bacteria in Central Nervous System Tumors: Opportunities and Challenges
    Zhang, Rui
    Li, Xueying
    Zhang, Si
    MICROORGANISMS, 2024, 12 (06)
  • [35] The Bereavement Experience for Partners of Patients With Central Nervous System Tumors
    Whisenant, Meagan S.
    Crane, Stacey
    Stewart, Mackenzie
    Milbury, Kathrin
    ONCOLOGY NURSING FORUM, 2022, 49 (02) : 151 - 157
  • [36] Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors
    Robison, Nathan J.
    Yeo, Kee Kiat
    Berliner, Adrian P.
    Malvar, Jemily
    Sheard, Michael A.
    Margol, Ashley S.
    Seeger, Robert C.
    Rushing, Teresa
    Finlay, Jonathan L.
    Sposto, Richard
    Dhall, Girish
    JOURNAL OF NEURO-ONCOLOGY, 2018, 138 (01) : 199 - 207
  • [37] Central Nervous System Tumors in Uganda: Outcomes of Surgical Treatment and Complications Assessed Through Telephone Survey
    Kakusa, Bina W.
    Xu, Linda W.
    Vaca, Silvia D.
    Nalwanga, Juliet
    Kiryabwire, Joel
    Ssenyonjo, Hussein
    Mukasa, John
    Muhumuza, Michael
    Haglund, Michael M.
    Grant, Gerald A.
    WORLD NEUROSURGERY, 2019, 129 : E866 - E880
  • [38] Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections
    Wright, Karen D.
    Panetta, John C.
    Onar-Thomas, Arzu
    Reddick, Wilburn E.
    Patay, Zoltan
    Qaddoumi, Ibrahim
    Broniscer, Alberto
    Robinson, Giles
    Boop, Frederick A.
    Klimo, Paul, Jr.
    Ward, Deborah
    Gajjar, Amar
    Stewart, Clinton F.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (01) : 27 - 35
  • [39] Prevalence of JC polyomavirus large T antigen sequences among Iranian patients with central nervous system tumors
    Sadeghi, Farzin
    Salehi-Vaziri, Mostafa
    Ghodsi, Seyed Mohammad
    Alizadeh, Ahad
    Bokharaei-Salim, Farah
    Saroukalaei, Sedigheh Taghinezhad
    Mirbolouk, Mohammadhossein
    Monavari, Seyed Hamidreza
    Keyvani, Hossein
    ARCHIVES OF VIROLOGY, 2015, 160 (01) : 61 - 68
  • [40] An Integrated Analysis of Tumor Purity of Common Central Nervous System Tumors in Children Based on Machine Learning Methods
    Yang, Jian
    Wang, Jiajia
    Tian, Shuaiwei
    Wang, Qinhua
    Zhao, Yang
    Wang, Baocheng
    Cao, Liangliang
    Liang, Zhuangzhuang
    Zhao, Heng
    Lian, Hao
    Ma, Jie
    FRONTIERS IN GENETICS, 2021, 12